New Delhi, July 23 (IANS) India’s pharma and healthcare sector recorded 65 deals worth $13.9 billion in the second quarter of 2026, a report said on Thursday.Despite lower activity, overall deal values remained resilient, the report from Grant Thornton Bharat said. Excluding a $11.8 billion deal which was the largest overseas purchase by an Indian pharmaceutical company, overall deal values still rose 12 per cent over the previous quarter.”The quarter reflects a clear strategic shift in India’…
Latest QIPs News & Updates
New Delhi, July 20 (IANS) India’s consumer sector remained resilient recording 97 deals worth $981 million in the second quarter of 2026 even as deal volumes and values eased from the prior quarter, a report said on Monday.The report from Grant Thornton said overall deal volumes eased 34 per cent quarter‑on‑quarter and deal values moderated 33 per cent.The deal data reflected a more selective investment environment even as strategic acquisitions and growth‑stage investments continued acr…
New Delhi, June 8 (IANS) Deal activity in India cooled in May 2026 from an exceptionally strong April, with 196 transactions worth $11 billion, a report said on Monday.Excluding public market activity, the month witnessed 190 M&A and PE deals worth $10.2 billion, marking an ease of 10 per cent in volumes and a 53 per cent ease in values compared to the previous month.Large-ticket deals continued to shape monthly totals despite a pullback in overall volumes and values.The month’s volume was s…
New Delhi, May 13 (IANS) India recorded 220 deals worth $22.8 billion in April 2026 because of a substantial surge in outbound mergers and acquisitions (M&A) activity despite ongoing global macroeconomic and geopolitical uncertainties, a report showed on Wednesday.The report by Grant Thornton Bharat highlighted that five billion-dollar deals contributed $17.4 billion during the month, accounting for nearly 80 per cent of the total deal value.Moreover, M&A activity emerged as the key driv…